Literature DB >> 17123771

Local recurrence in breast carcinoma patients with T(1-2) and 1-3 positive nodes: indications for radiotherapy.

E Yildirim1, U Berberoglu.   

Abstract

AIMS: To investigate the relationship between local recurrence (LR) and distant recurrence (DR) and to determine a subgroup of patients who could benefit from radiotherapy among breast carcinoma patients with T(1-2) and N(1a).
METHODS: Univariate and multivariate Cox regression analyses were carried out in the retrospective data of 326 eligible patients.
RESULTS: Fourteen (4.3%) patients had LR and 46 (14.1%) patients suffered DR, in their follow-up periods. The multivariate time-dependent Cox model for DR showed that ratio of positive nodes (PN) (p=0.004; hazard ratio (HR), 1.05; 95% confidence interval (CI), 1.02-1.09) and LR (p=0.05; HR, dependent on time) were strongly associated with DR. In the multivariate Cox analysis for LR, age (<or=35 years vs >35 years; p<0.0001; HR, 6.8; CI, 2.3-19.9), lymphatic vascular invasion (LVI) (yes vs no; p=0.03; HR, 3.3; CI, 1.2-9.8), and a ratio of PN (>15% vs <or=15%; p<0.0001; HR, 13.0; CI, 3.9-42.0) were the most important prognostic factors. Whereas patients with 2 or 3 risk factors were accepted as the high risk group for LR, those with no or 1 risk factor were considered as the low risk group. These groups had a 23% LR rate and a 2.7% LR rate, respectively (p<0.0001).
CONCLUSIONS: This report confirmed the importance of local recurrence for distant recurrence. Age, ratio of PN and LVI were the most important prognostic factors for LR. The T(1-2) and N(1a) patients who had 2 or 3 risk factors might benefit from radiotherapy.

Entities:  

Mesh:

Year:  2006        PMID: 17123771     DOI: 10.1016/j.ejso.2006.10.022

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.

Authors:  Audree B Tadros; Tracy-Ann Moo; Michelle Stempel; Emily C Zabor; Atif J Khan; Monica Morrow
Journal:  Breast Cancer Res Treat       Date:  2020-01-14       Impact factor: 4.872

2.  Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.

Authors:  Shirin Muhsen; Tracy-Ann Moo; Sujata Patil; Michelle Stempel; Simon Powell; Monica Morrow; Mahmoud El-Tamer
Journal:  Ann Surg Oncol       Date:  2018-03-21       Impact factor: 5.344

3.  Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.

Authors:  Nüvit Duraker; Bakir Bati; Zeynep Civelek Çaynak; Davut Demir
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

4.  Location and Frequency of Residual Breast Tissue after Mastectomy.

Authors:  Ibrahim Ustun; Kemal Beksac; Olcay Kandemir; Ugur Berberoglu
Journal:  Breast Care (Basel)       Date:  2019-03-14       Impact factor: 2.860

5.  Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis.

Authors:  Nüvit Duraker; Bakır Batı; Davut Demir; Zeynep Civelek Caynak
Journal:  ISRN Oncol       Date:  2011-10-12

6.  Post-mastectomy radiotherapy can improve survival in breast cancer patients aged 35 years or younger with four or more positive nodes but not in one to three positive nodes.

Authors:  Sangang Wu; Qun Li; Juan Zhou; Jiayuan Sun; Fengyan Li; Qin Lin; Zhenyu He
Journal:  Ther Clin Risk Manag       Date:  2014-10-09       Impact factor: 2.423

7.  Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.

Authors:  Abram Recht; Elizabeth A Comen; Richard E Fine; Gini F Fleming; Patricia H Hardenbergh; Alice Y Ho; Clifford A Hudis; E Shelley Hwang; Jeffrey J Kirshner; Monica Morrow; Kilian E Salerno; George W Sledge; Lawrence J Solin; Patricia A Spears; Timothy J Whelan; Mark R Somerfield; Stephen B Edge
Journal:  Ann Surg Oncol       Date:  2016-09-19       Impact factor: 5.344

8.  Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy.

Authors:  San-Gang Wu; Si-Juan Huang; Juan Zhou; Jia-Yuan Sun; Han Guo; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Zhen-Yu He
Journal:  Radiat Oncol       Date:  2014-12-12       Impact factor: 3.481

9.  Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.

Authors:  Yu-Li Su; Shan-Hsuan Li; Yen-Yang Chen; Hui-Chun Chen; Yen Tang; Cheng-Hua Huang; Fong-Fu Chou; Shih-Chung Wu; Kun-Ming Rau
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.